Symphony Biosciences Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

Symphony Biosciences General Information

Description

Developer of cancer drugs designed to help treat solid tumors. The company focuses on treating cancer diseases using biomaterials, enabling healthcare professionals to improve survival rates, reduce adverse effects, and offer new hope to patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 570 Westwood Plaza, Building Trades 114
  • Room 6530
  • Los Angeles, CA 90095
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 570 Westwood Plaza, Building Trades 114
  • Room 6530
  • Los Angeles, CA 90095
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Symphony Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 21-Nov-2024 Completed Startup
4. Accelerator/Incubator 01-Jan-2024 Completed Startup
3. Accelerator/Incubator 26-Jul-2023 Completed Startup
2. Accelerator/Incubator 07-Oct-2022 Completed Startup
1. Early Stage VC 01-Oct-2022 Completed Startup
To view Symphony Biosciences’s complete valuation and funding history, request access »

Symphony Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Symphony Biosciences Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Station 41 Accelerator/Incubator
Magnify Accelerator/Incubator
MassChallenge Accelerator/Incubator
UCI Beall Applied Innovation Accelerator/Incubator
SBIR Advisors Corporation Minority
You’re viewing 5 of 6 investors. Get the full list »

Symphony Biosciences FAQs

  • When was Symphony Biosciences founded?

    Symphony Biosciences was founded in 2021.

  • Where is Symphony Biosciences headquartered?

    Symphony Biosciences is headquartered in Los Angeles, CA.

  • What is the size of Symphony Biosciences?

    Symphony Biosciences has 3 total employees.

  • What industry is Symphony Biosciences in?

    Symphony Biosciences’s primary industry is Drug Discovery.

  • Is Symphony Biosciences a private or public company?

    Symphony Biosciences is a Private company.

  • What is Symphony Biosciences’s current revenue?

    The current revenue for Symphony Biosciences is .

  • Who are Symphony Biosciences’s investors?

    Station 41, Magnify, MassChallenge, UCI Beall Applied Innovation, and SBIR Advisors are 5 of 6 investors who have invested in Symphony Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process